This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
From Imitation to Innovation: Zongshen Industrial Group
Shih, Willy; Dai, Nancy HuaCase HBS-610057-EService and Operations ManagementAs Zuo Zongshen drove the transformation of the Zongshen Industrial Group from an early imitator in the motorcycle business to a company that increasingly focused on innovation as a way to get out of the hyper-competitive commodity business, he continually faced new challenges. The company had become a leader in gasoline powered motorcycles and small gas engines, but increasing taxes and restrictions on the use of motorcycles in congested urban a...Starting at €8.20
-
BeiGene, PowerPoint Supplement
Shih, Willy; Zhang, JimmyCase HBS-618043-EStrategyPowerPoint slides for case 618033.Starting at €8.20
-
Austal, Ltd. B
Shih, Willy; Pierson, Margaret; Lau, DawnCase HBS-613026-EStrategySupplement for case 613025Starting at €8.20
-
Supply Chain Management
Shih, WillyCase HBS-619023-EService and Operations ManagementThis note on supply chain management provides background for the seven class supply chain module in the Technology & Operations Management required curriculum course taught at the Harvard Business School. This module includes four broad topics: sourcing and supply chain structure, supply chain coordination, coping with uncertain demand, and supply chain visibility.Starting at €8.20
-
MoviePass
Shih, WillyCase HBS-619052-EStrategyMitch Lowe, the CEO of MoviePass, was having trouble convincing people of the viability of the company's business model. The company was building a multi-sided platform, and was planning to extract value from increasing traffic to movie theaters through a number of mechanisms. It also appeared to making assumptions around its flat-rate pricing model. By making some assumptions, this case affords an opportunity for students to practice with discov...Starting at €8.20
-
MoviePass, Teaching Note
Shih, WillyTeaching Note HBS-620023-EStrategyExamines MoviePass business model and considers the benefits of discovery-driven planning Teaching note to case 619052. This case looks at MoviePass, a matching platform designed to encourage more theatrical movie-going. The purpose is to examine the assumptions underpinning the company's business model and consider the benefits of discovery-driven planning.Starting at €0.00
-
PadFone vs. FonePad
Shih, Willy; Chai, SenCase HBS-614023-EStrategyTo maximize their effectiveness, color cases should be printed in color. To Jonney Shih, Chairman of ASUSTek Computer, the introduction of Apple's iPad made clear the need to transition his company to a new cloud-computing era. But the company's roots in the manufacture of Windows-powered desktop and notebook PCs bounded the creativity of his design and engineering teams. The case examines the ASUS's efforts to get into the smartphone business, l...Starting at €8.20
-
HP Labs in Singapore
Shih, Willy; Agarwal, Pankaj; Chi, ChristineCase HBS-612080-EWhen HP established a branch of its corporate research lab in Singapore, the government played a key role through its Economic Development Board (EDB). Chris Whitney, the lab's director, sought to generate revenue from the lab's innovations, making it financially independent from corporate funding. The case explores HP's history in Singapore, and the role of the EDB in encouraging the growth of local R&D capabilities. The case poses questions on ...Starting at €8.20
-
Raising the Level of Abstraction
Shih, WillyCase HBS-614019-EStrategyThis technical note discuss abstraction as a way of generalizing a process or component for wider application. By hiding complexity inside a module, abstraction enables system designers o think at a higher level. This lower entry barriers to using (and reusing) a complex technology.Starting at €8.20
-
BeiGene, Teaching Note
Shih, Willy; Zhang, JimmyTeaching Note HBS-618039-EStrategyTeaching Note for 618033 BeiGene. BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window of opportunity to develop drug candidates toward known targets with known mechanisms of actions that would allow it to become first-in-class in Ch...Starting at €0.00